Voice Treatment for Individuals With Parkinson's Disease This work was supported in part by NIH-NIDCD R01 DC01150. Successful treatment of speech disorders in individuals with progressive neurological diseases can be challenging. Hillman, Gress, Haugraf, Walsh, and Bunting (1990, p. 308) stated that “voice treatment for disorders that are degenerative is controversial since there is no expectation ... Article
Article  |   October 01, 2007
Voice Treatment for Individuals With Parkinson's Disease
Author Affiliations & Notes
  • Lorraine Ramig
    University of Colorado-Boulder, National Center for Voice and Speech, Denver, CO
    Columbia University, New York, NY
  • Cynthia Fox
    National Center for Voice and Speech, Denver, CO
    Department of Neurology, Tucson, AZ
Article Information
Speech, Voice & Prosodic Disorders / Voice Disorders / Hearing & Speech Perception / Acoustics / Special Populations / Older Adults & Aging / Speech, Voice & Prosody / Articles
Article   |   October 01, 2007
Voice Treatment for Individuals With Parkinson's Disease
SIG 15 Perspectives on Gerontology, October 2007, Vol. 12, 2-11. doi:10.1044/gero12.1.2
SIG 15 Perspectives on Gerontology, October 2007, Vol. 12, 2-11. doi:10.1044/gero12.1.2
This work was supported in part by NIH-NIDCD R01 DC01150.
Successful treatment of speech disorders in individuals with progressive neurological diseases can be challenging. Hillman, Gress, Haugraf, Walsh, and Bunting (1990, p. 308) stated that “voice treatment for disorders that are degenerative is controversial since there is no expectation for recovery of function or that any improvement secondary to speech language pathology intervention will be maintained in the long term.” Individuals with idiopathic Parkinson disease (PD) have been particularly resistant to speech treatment with the conventional wisdom being summarized by the statement, “changes observed in the treatment room disappear on the way to the parking lot” (Greene, 1980; Sarno, 1968). The consensus that speech treatment has not been effective for individuals with PD is, perhaps, the basis for the report that of the 75–89% of these individuals with voice and speech disorders only 3–4% receive speech treatment (Hartelius & Svensson, 1994).
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
Become a SIG Affiliate
Pay Per View
Entire SIG 15 Perspectives on Gerontology content & archive
24-hour access
This Issue
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.